4.5 Editorial Material

Optimal sequence of systemic therapy after sorafenib failure in patients with hepatocellular carcinoma

Journal

CLINICAL AND MOLECULAR HEPATOLOGY
Volume 26, Issue 3, Pages 305-308

Publisher

KOREAN ASSOC STUDY LIVER
DOI: 10.3350/cmh.2020.0096

Keywords

Carcinoma; Hepatocellular; Sorafenib; Protein kinase inhibitors

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available